Literature DB >> 1326553

The cGMP phosphodiesterase-transducin complex of retinal rods. Membrane binding and subunits interactions.

P Catty1, C Pfister, F Bruckert, P Deterre.   

Abstract

cGMP-specific phosphodiesterase (PDE) of vertebrate retinal rod outer segments (ROS) is composed of two catalytic subunits (PDE alpha and PDE beta) and two identical inhibitory subunits (PDE gamma). Native PDE alpha beta gamma 2 is peripherally bound to the membranes of ROS discs. We studied quantitatively its partition between soluble and membrane-bound fractions in ROS homogenates. In the presence of its activator, the alpha-subunit of transducin loaded with a triphosphate guanine nucleotide (T alpha*), PDE displayed a greatly enhanced membrane binding. Neither the purified PDE gamma.T alpha* complex, nor the PDE alpha beta and PDE alpha beta gamma forms of active PDE, showed a membrane binding comparable to that of PDE alpha beta gamma 2 in the presence of T alpha*. The T alpha*-activated PDE is therefore an undissociated complex tightly bound to the ROS membranes. Using limited proteolysis, we showed that the membrane anchoring of the whole complex implies not only PDE (mainly by the C terminus of PDE beta) but also both termini of T alpha*. The membrane binding of the purified PDE alpha beta species was also enhanced in the presence of T alpha*; a direct link would therefore exist between the activator and the catalytic subunits. From this work emerges a plausible structural model of the T alpha*-activated PDE, with its internal interactions and its sites of anchoring into the ROS membrane.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1326553

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Complementary interactions of the rod PDE6 inhibitory subunit with the catalytic subunits and transducin.

Authors:  Lian-Wang Guo; Abdol R Hajipour; Arnold E Ruoho
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

2.  Mechanism for the regulation of mammalian cGMP phosphodiesterase6. 2: isolation and characterization of the transducin-activated form.

Authors:  Akio Yamazaki; Masahiro Tatsumi; Vladimir A Bondarenko; Sadamu Kurono; Naoka Komori; Hiroyuki Matsumoto; Isao Matsuura; Fumio Hayashi; Russell K Yamazaki; Jiro Usukura
Journal:  Mol Cell Biochem       Date:  2010-02-23       Impact factor: 3.396

Review 3.  Phototransduction in mouse rods and cones.

Authors:  Yingbin Fu; King-Wai Yau
Journal:  Pflugers Arch       Date:  2007-01-17       Impact factor: 3.657

Review 4.  The retinal cGMP phosphodiesterase gamma-subunit - a chameleon.

Authors:  Lian-Wang Guo; Arnold E Ruoho
Journal:  Curr Protein Pept Sci       Date:  2008-12       Impact factor: 3.272

Review 5.  Light-dependent compartmentalization of transducin in rod photoreceptors.

Authors:  Nikolai O Artemyev
Journal:  Mol Neurobiol       Date:  2008-04-19       Impact factor: 5.590

6.  Responses of the phototransduction cascade to dim light.

Authors:  G Langlois; C K Chen; K Palczewski; J B Hurley; T M Vuong
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

7.  Domain organization and conformational plasticity of the G protein effector, PDE6.

Authors:  Zhixian Zhang; Feng He; Ryan Constantine; Matthew L Baker; Wolfgang Baehr; Michael F Schmid; Theodore G Wensel; Melina A Agosto
Journal:  J Biol Chem       Date:  2015-03-25       Impact factor: 5.157

8.  Stochastic simulation of activation in the G-protein cascade of phototransduction.

Authors:  T D Lamb
Journal:  Biophys J       Date:  1994-10       Impact factor: 4.033

9.  Mechanisms of mutant PDE6 proteins underlying retinal diseases.

Authors:  Kota N Gopalakrishna; Kimberly Boyd; Nikolai O Artemyev
Journal:  Cell Signal       Date:  2017-06-02       Impact factor: 4.315

10.  IQCB1 and PDE6B mutations cause similar early onset retinal degenerations in two closely related terrier dog breeds.

Authors:  Orly Goldstein; Jason G Mezey; Peter A Schweitzer; Adam R Boyko; Chuan Gao; Carlos D Bustamante; Julie Ann Jordan; Gustavo D Aguirre; Gregory M Acland
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-25       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.